Loading organizations...
SternAegis Ventures operates as the venture capital financing arm within Aegis Capital Corp.'s Private Equity Banking group. The entity provides venture capital and private equity solutions, specializing in connecting promising companies with the necessary capital for growth. Its core offering involves structuring and facilitating investments into early-stage and developing enterprises, leveraging its position within a broader financial services framework to deliver comprehensive financing strategies.
Adam Stern founded SternAegis Ventures in June 2012, building on his extensive experience in private equity and venture capital. Prior to establishing SternAegis, Mr. Stern held a significant role as Senior Managing Director at Spencer Trask Ventures, Inc. from 1997 to 2012. His career trajectory and expertise in managing structured finance initiatives provided the foundational insight for creating a dedicated venture financing unit within a full-service financial firm.
The firm primarily serves companies seeking capital to develop and scale their operations across various sectors. SternAegis Ventures aims to be a strategic financial partner, guiding companies through critical growth phases by providing access to investment capital and advisory support. Its long-term vision centers on fostering innovation and value creation by empowering entrepreneurial ventures with robust financial backing and expertise.
Key people at SternAegis Ventures.
Key people at SternAegis Ventures.
SternAegis Ventures has 5 tracked investments across 4 companies. The latest tracked deal is $11.8M Series A in Amplifica in October 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 24, 2022 | Amplifica | $11.8M Series A | Sternaegis Ventures | — |
| Jul 5, 2022 | Orchestra BioMed | $110.0M Series D | Roderick Wong | Medtronic, Perceptive Advisors, Terumo Corporation |
| Jun 30, 2020 | Outstanding Foods | $5.0M Other Equity | Sternaegis Ventures | Javale Mcgee |
| Jun 1, 2020 | DermaSensor | $12.0M Series A | Christopher Dewey, David Matlin, Maurice Ferre, M.D., Sternaegis Ventures | Highland Capital Partners, Octopus Ventures, Sonder Capital, Anil Sethi, Martin Varsavsky, Miami Angels |
| Jul 10, 2019 | Orchestra BioMed | $34.0M Series B | Perceptive Advisors, RTW Investments, Soleus Capital | Terumo Corporation |